Document ID: chunk:federal_register_of_legislation:F2023L00941:reg:9:p2
Version: federal_register_of_legislation:F2023L00941
Segment Type: reg
Provision Reference: reg 9 (pt 2/6)
Character Range: 7245–10297

within the 10 years before the clinical onset of peripheral neuropathy;
Note: Alcohol consumption is calculated utilising the Australian Standard of 10 grams of alcohol per standard alcoholic drink.
(15)      inhaling, ingesting or having cutaneous contact with a chemical from the specified list of chemicals (short term exposure);
(a)          on at least 30 occasions within a continuous period of 6 months before the clinical onset of peripheral neuropathy; and
(b)          where exposure has ceased before the clinical onset of peripheral neuropathy, then that onset occurred within 3 months of cessation;
Note: specified list of chemicals (short term exposure) is defined in the Schedule 1 - Dictionary.
(16)      inhaling, ingesting or having cutaneous contact with a chemical from the specified list of chemicals (long term exposure):
(a)          on more days than not for at least 1 year before the clinical onset of peripheral neuropathy; and
(b)          where exposure has ceased before the clinical onset of peripheral neuropathy, then that onset occurred within 3 months of cessation;
Note: specified list of chemicals (long term exposure) is defined in the Schedule 1 - Dictionary.
(17)      having a severe substance use disorder involving inhalation of a substance from the specified list of substances at the time of the clinical onset of peripheral neuropathy;
Note: severe substance use disorder and specified list of substances are defined in the Schedule 1 - Dictionary.
(18)      inhaling, ingesting or having cutaneous contact with a chemical agent contaminated by 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD) within the 30 days before the clinical onset of peripheral neuropathy;
Note: inhaling, ingesting or having cutaneous contact with a chemical agent contaminated by 2,3,7,8-tetrachlorodibenzo-para-dioxin (TCDD) is defined in the Schedule 1 - Dictionary.
(19)      having an episode of acute cholinergic poisoning from exposure to an organophosphorus compound or a carbamate insecticide within the 2 months before the clinical onset of peripheral neuropathy;
Note: acute cholinergic poisoning and organophosphorus compound are defined in the Schedule 1 - Dictionary.
(20)      being poisoned with an agent from the specified list of agents, as demonstrated by clinical, haematological or biochemical evidence, within the 30 days before the clinical onset of peripheral neuropathy;
Note: specified list of agents is defined in the Schedule 1 - Dictionary.
(21)      having a nutritional deficiency as specified at the time of the clinical onset of peripheral neuropathy;
Note: nutritional deficiency as specified is defined in the Schedule 1 - Dictionary.
(22)      having hypophosphataemia while undergoing total parenteral nutrition at the time of the clinical onset of peripheral neuropathy;
(23)      taking a drug from the specified list of drugs that cannot be ceased or substituted, at the time of the clinical onset of peripheral neuropathy;
Note: specified list of drugs that cannot be ceased or substituted is